Meckler Jeffrey A 4
4 · Indaptus Therapeutics, Inc. · Filed Nov 26, 2024
Insider Transaction Report
Form 4
Meckler Jeffrey A
DirectorCo-Chief Executive Officer
Transactions
- Award
Common stock
2024-11-25$1.18/sh+42,553$50,000→ 202,859 total - Award
Common Stock Warrants
2024-11-25$1.18/sh+42,553$50,000→ 42,553 totalExercise: $1.05Exp: 2029-11-25→ Common Stock (42,553 underlying)
Footnotes (1)
- [F1]The Reporting Person acquired 42,553 shares of common stock and 42,553 warrants to purchase common stock from the Issuer for an aggregate purchase price of $49,999.78.